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Abstract:
Background:
Immigrants to developed countries are a major source of  TB. Therefore amongst strategies adopted for TB control in de-
veloped countries include; 1) Screening immigrants at ports of  entry referred to as “Port of  Arrival Screening” (PoA) and 
2) Passive screening (PS) for TB which means screening immigrants through general practices, hospitals, chest-clinics and 
emergency departments. Evidence of  the effectiveness and cost effectiveness of  these strategies is not consistent.
Objective:
Evaluate efficiency of  active PoA TB screening for immigrants from TB endemic-regions compared with Passive Screening 
of  immigrant-populations from TB endemic-regions.
Methods:
Major electronic-databases and reference lists of  relevant studies were searched. Experts of  immigrants’ TB screening were 
contacted for additional studies published or unpublished.
Systematic search of  major databases identified only retrospective cohort-studies. Their qualities were assessed using Scot-
tish Intercollegiate Guidelines Network (SIGN) methodological checklist for comparative cohort-studies.
Results:
Systematic electronic searches identified 1443 citations. Of  these 74 studies were retrieved for evaluation against the review’s 
inclusion/exclusion criteria (see study inclusion/exclusion criteria). Four studies met the inclusion criteria (figure 2) which 
were low in the evidence hierarchy of  primary effectiveness studies and had heterogeneities between them. Thus descriptive 
data-synthesis was performed.
Proportionately PoA screening had the lowest percentage of  receipt of  tuberculin skin test (TST) and the highest percent-
age of  non-attendance for TST reading (table 2). Active PoA screening reduced infectiousness by 34% compared to 30% 
by passive screening and new entrants screened at PoA were 80% less likely to be hospitalised Odds ratio (OR) = 0.2 (95% 
confidence interval (CI) 0.1 – 0.2).
Economic analysis:
One cost effectiveness analysis was found that compared the costs of; active PoA screening, general practice screening and 
homeless screening groups. The cost of  detecting a case of  TB were; £1.26, £13.17and £96.36 for PS, homeless screening 
and active PoA screening respectively. The cost of  preventing a case of  TB were; £6.32, £23.00 and £10.00 for PS, homeless 
screening and PoA screening respectively, showing there is little difference between the different strategies.
Conclussion:
Active PoA screening is worth doing with significant benefits including early identification of  risk groups with possible 
timely treatment/chemoprophylaxis intervention, prevention of  transmission by significantly reducing infectiousness with 
subsequent avoidance of  hospitalisation in active PoA screening group.
http://dx.doi.org/10.4314/ahs.v14i3.23
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Background
 Historically, human migration had had a major impact 
on the spread of  infectious diseases such as TB 1. Early 
nineteenth century, it was estimated that 25% of  deaths 
in Western Europe were attributable to TB 2. Through 
travel TB spread to different parts of  the world resulting 
in major epidemics in parts of  sub-Saharan and central 
Africa, South-East Asia and the Americas 2. Following 
improvements in housing, nutrition and discoveries in 
antibiotics in the 1950s, incidence of  TB fell in Western 
Europe and North America 1. However incidence con-
tinued to rise in resource-limited-settings3.
In the face of  globalisation with western economies 
booming, availability of  cheap travel, political instabil-
ity, man-made and natural disasters in less developed 
countries compounded by economic hardship, econom-
ic migration to the industrialised world has increased 
tremendously 4, majority of  who come from high TB 
endemic-regions 5. Accordingly research evidence sup-
ports that migrants from TB endemic-countries con-
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Figure 1 – Pathway for screening new entrants
tinue to have relatively high rates of  latent TB for years 
after arrival in low TB prevalence countries 6,7. Howev-
er a study of  the transmission rates of  mycobacterium 
(M) TB amongst different populations in Norway 8 to 
determine the genetic diversity of  the population of  M. 
TB isolates in TB patients and the degree of  cluster-
ing of  M. TB detected relatively little TB transmission 
from foreign-born residents to the general population. 
But there is consistent evidence that incidence of  TB 
is higher amongst foreign-born ethnic-minority popula-
tions than native born-populations in the west; United 
States (US) 9, United Kingdom (UK) 10, Canada 11 and 
Switzerland 12. It was against this background in the 
late 20th century, some industrialised countries insti-
tuted port of  entry TB screening for immigrants from 
high TB incidence regions; UK5,16,27, US15,18 and 
Canada11. However evidence of  the effectiveness and 
cost effectiveness of  new entrants’ TB screening is in-
consistent. It had been shown to be; effective 13,14,15, 
both effective and cost effective 16 but some research-
ers suggested no evidence of  effectiveness 17,18,19 im-
plying inconsistent public health research evidence for 
compulsory TB screening of  new immigrants. Thus, 
this review reviewed the effectiveness and cost effec-
tiveness of  new entrants’ TB screening schemes for im-
migrants from TB endemic regions to low TB prevalent 
countries.
Epidemiology    
It has been estimated that of  the one third of  the world's 
population infected with TB, 8 million developed active 
TB with 5 000 deaths each day; 1.5 million occurred in 
Sub-Saharan Africa, 3 million in South-East Asia and 
over a quarter of  a million in Eastern Europe 20.
England like many industrialised countries where new 
entrants screening for TB is being practised on arriv-
al, risk of  TB is significantly higher in ethnic-minority 
groups; the crude incidence of  active TB in native-born 
population in 1998 was 4.4/100 000 compared with 
121–210/100 000 in ethnic-minorities 21. Similar evi-
dence was supported in California 22 and Montreal 23.
In England trends showed that TB rates peaked in early 
twentieth century with incidence of  300/100 000 per 
year which declined to 10/100 000 in 1987. The rates 
then fluctuated until 2007 with 14/100 000 population. 
However this represented a small increase of  0.7% 
compared with 2006 24.
Current Service Provision (UK)
In the UK new entrants TB screening guidelines were 
adapted from the national recommendations 5 by the 
government's independent health watchdog (NICE). 
Figure 1 shows a typical pathway for the screening of  
new entrants.
On arrival new entrants from regions with TB preva-
lence of  >/= 40/100 000 are screened verbally using a 
simple questionnaire. If  no evidence of  TB was found 
and the person has BCG scar, no action is taken. All 
new entrants under 35 years and those without BCG 
scar are subjected to TST test. If  the test is negative 
(grades 0 or 1) they are offered BCG vaccination. If  
the test is positive (grades 2 or above) with/without 
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signs and symptoms they are given anti-TB treatment/
chemoprophylaxis respectively. However if  the test is 
less reliable, they should be considered for interferon-
gamma immunological testing if  available. On the other 
hand if  the test is not conclusive, the person is referred 
for further investigations using chest x-ray/culture. If  
the result is consistent with active TB they are put on 
anti-TB treatment.
Description of  Interventions
Any TB screening schemes instituted at PoA for new 
entrants from TB endemic-regions intending to stay 
in low TB prevalent country for at least six-months. 
The review aims to look at efficiency of  the different 
schemes from host country’s government perspective. 
Therefore any studies that investigated the effective-
ness of  screening subjects in their own countries were 
excluded because costs of  such screening schemes are 
borne by subjects or their governments.
Methodology for the Identification of  Effectiveness 
Studies
A comprehensive systematic search of  the general 
bibliographic databases; MEDLINE, EMBASE and 
PUBMED was conducted in June 2008. The data 
sources and periods covered were;
-MEDLINE from 1950 – 2008
-EMBASE from 1977 – 2008
-PUBMED and COCHRANE library databases with 
no date limits. The search strategies used are available 
on request. 
-TB journals and websites eg. International union 
against TB (IUATB), Thorax, World health organisa-
tion (WHO) and internet searches using Google search 
engines.
-Reference lists of  studies thought to be relevant to the 
review were scanned for any additional studies.
 -Experts in new immigrants’ screening were contacted 
for relevant information and knowledge of  unpublished 
work on the subject.
Study Inclusion/Exclusion Criteria
Every retrieved citation was checked against a predeter-
mined inclusion/exclusion criteria form (available on 
request). One reviewer (AS) checked the title and ab-
stract of  every article, which were independently veri-
fied by the second reviewer (MA). Any disagreement 
was discussed and consensus was achieved. The follow-
ing shows the population, intervention, comparator and 
outcomes (PICO) of  included studies;
Population: Immigrants from TB endemic-regions with 
TB prevalence of  >/= 40/100 000 population as rec-
ommended by British Thoracic Society 5.
Intervention: (See description of  intervention). Studies 
were excluded if  they had an inappropriate/no compa-
rator arm in the study.
Comparator: PS of  immigrants' populations from TB 
endemic-regions through general practitioners and oth-
er modes of  routine practice. It was considered for pa-
tients who had sought medical consultation either due 
to signs/symptoms of  TB irrespective of  prior screen-
ing history or for some other condition during which 
TB was accidentally diagnosed.
Outcome Measures of  Interest:
-BCG vaccinations and chemoprophylaxis treatment 
prior and after screening respectively
-Number of  latent and active TB cases detected
-Treatment outcomes of  active TB; cured, treatment 
complete, died, failed, defaulted and transferred out de-
fined according to WHO guideline 25. 
Study Design: For inclusion, studies must be of  the fol-
lowing designs;
-Cluster randomised trial
-Prospective cohort studies and 
-Retrospective cohort studies
Quality Assessment
Two reviewers (AS and MA) independently quality as-
sessed the included studies using the quality assessment 
methodological checklist for cohort studies 26, in order 
to minimise bias and errors in the conduct and analysis 
of  primary studies. The criteria used to decide whether 
a study was of  very good quality, good quality or poor 
is given below;
1. If  the study met all important characteristic 
quality attributes : very good
2. If  the study inadequately reported one or more 
of  the quality attributes : good
3. If  the study did not met one or more quality 
attributes : poor
NB: See study quality for the quality attributes
Any disagreement was discussed and consensus 
achieved. A detail quality assessment methodological 
checklist is available on request.
Data Extraction
Using a predetermined data extraction form that was 
piloted on a sample of  studies, one reviewer (AS) ex-
tracted the data presented in tabular forms (table 1 and 
2).This allowed comparison between different studies 
in the evaluation of  the effectiveness of  the interven-
tions in the studies. Extracted data was independently 
verified by MA. Any disagreement was discussed and 
consensus achieved.
Results of  Included Effectiveness Studies
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Figure 2 – QUORUM FLOWCHART SHOWING STUDY SELECTION PROCESS OF PRIMARY EFFEC-
TIVENESS STUDIES
Number of  Studies Identified: 1443 citations were iden-
tified from the initial electronic searches. Of  these 74 
studies were retrieved for evaluation against the review's 
inclusion/exclusion criteria. 70 studies were excluded. 
Four retrospective cohort studies were included shown 
in figure 2. There were no cluster-randomised or pro-
spective cohort studies. This may be reasonable given 
the risk and practical challenges of  random allocation 
of  people at high risk of  TB to a non-intervention on 
entry. The studies have common objective, applied the 
same inclusion/exclusion criteria but reported different 
outcome measures.
Study Quality
Qualities of  the studies were unanimously agreed as 
poor by the two reviewers, given the following reasons;
• They were of  design which is lower in the evi-
dence-based hierarchy for effectiveness studies
• Only Ormerod study reported total number 
of  study population and effect size in the comparator 
group
• There were high rates of  non-respondents in 
the studies; Bothamley et al and Ormerod
• Only Monney et al considered the validity and 
reliability of  the assessment tools used
• Ormerod and Verver et al did not report total 
number of  study participants
• All failed to report the relative risk which would 
have been helpful in assessing the risk of  TB in the 
groups with significant heterogeneities.
Studies’ Characteristics
Four studies met the inclusion criteria that were all ret-
rospective cohort studies. The details of  these studies 
and populations are provided in table 1. The results of  
included studies are presented in tabular forms; 
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Study Study design Country Sex Age (median age) Study population 






Not specified Not specified. However for port of arrival group; 87 
(37%) were age < 16 and 28 (12%) were age > 35. 
Therefore 120 (51%) were > 16 years but < 35 years 
Port of arrival = 
1262     
Homeless = 172 
General practice not 
reported  
Monney et al (2005) Retrospective 
cohort study 
Switzerland Active screening 
Female=21% 





Male = 63% 
Active screening 
Median age = 26 (for 
females) 




Median age for female 
foreign workers* = 34 
Median age for female 
other** = 31 
Median age for Swiss 
female citizens = 64 
Active screening = 
13,507 
Passive screening not 
reported 




Not specified Age distribution was not specified. However 1379 were 
under the age of 30 years and 312 were either </= 15 
years or > 30 years for those screened 
Active port of entry 
screening = 1,085 
Passive screening = 
948 
Verver et al (2001) Retrospective 
cohort study 
Netherlands Active screening 
Female = 165 
(36%) 








Most common age range 25 
– 34 (for both sexes)  
Passive screening 
Most common age range 
25 – 34 (for both sexes) 
Active screening = 
454 




* Female foreign workers were those residing permanently in Switzerland 
**Female other were those from regions not classified as TB endemic regions 
Attendance for TB Screening (Bothamley et al, 
2002): Of  the four studies, Bothamley et al that assessed 
attendance for screening invitation showed active PoA 
had a smaller proportion of  attendance for screening 
upon invitation compared with passive screening. Al-
though a good proportion of  PoA received TST, it was 
lower than that of  passive screening. In terms of  failure 
to attend reading of  the TST, active PoA had the high-
est percentage shown in table 2. There were no signifi-
cant tests for these differences. However in the group 
of  homeless that comprised of  both recent immigrants 
and local residents, attendance for reading of  the TST 
was lower in the recent immigrants which was statis-
tically significant; 26.2% and 45.6% respectively (chi-
squared = 10.1 with p< 0.01).
Table 2
Different models of TB screening for immigrants 
Details Port of arrivals  General practice Homeless 
Invited for screening 1262 unknown 172 
Responded to 
invitation 235 (18.6%) 45 172 (100%) 
Received TST 181 (77%) 39 (86.7%) 172 (100%) 
Non attendance for 
TST reading 54 (29.8%) 9 (23.1) 45 (26.2%) 
BCG vaccination and chemoprophylaxis administration 
Bothamley et al 2002 Ormerod 1990 
Details PoA  GP Homeless PoA GP 
Study population 1262 Unknown 172 1085 948 
Received TST 181 39 172 1085 948 
Offered BCG 18 (14.2%) 14 (46.7%) 29 (16.9%) 413 (29.9%) 
Received BCG 18 (100%) 14 (100%) 27 (93.1%) 413 (100%) 
Started 
chemoprophylaxis 6 (4.7%) 8 (26.7%) 11 (6.4%) 40/322 (12.4%) 
Finished 
chemoprophylaxis 5 (83.3%) 2 (25%) 6 (54.5%) Not reported 
TABLE 2: Attendance for TB Screening 
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Monney et al 2005 Verver et al 2001 
Study details Active screening  Passive 
screening 
Active screening  Passive 
screening 
Proportion of TB cases 
that received treatment 
Active screening = 51 
cases (100%) 
Passive screening = 81 
cases (100%) 
Active screening = 454 
(100%) 
Passive screening = 368 
(100%) 
Cured  Active screening ~13 
(25%) 
Passive screening ~ 15 
(19%) 
Active screening = 139 
(31%) 
Passive screening = 83 
(23%) 
Completed treatment  Active screening ~30 
(59%) 
Passive screening ~ 49 
(61%) 
Active screening = 245 
(54%) 
Passive screening = 210 
(57%) 
Failure  Active screening ~ 2(3%) Passive screening ~ 1(1%) Not reported Not reported 
Dead  Active screening ~ 0(0%) Passive screening ~6(8%) Active screening = 0(0%) Passive screening = 2(1%) 
Default  Active screening ~2 (3%) Passive screening ~ 6(8%) Active screening = 
47(10%) 
Passive screening = 
36(10%) 
Transferred  Active screening ~ 5(10%) Passive screening ~ 2(3%) Active screening = 22(5%) Passive screening = 
27(7%) 
 
NB: Percentages and figures for column 2 in table 4 above are estimates (rounded up or down) derived from graph in which the authors 
presented the treatment outcomes without actual figures 
BCG Vaccinations and Chemoprophylaxis Administra-
tions: Bothamley et al and Ormerod studies assessed 
these outcomes. The highest proportion of  immigrants 
offered BCG vaccination in Bothamley was in the gen-
eral practice. However 100% of  both active PoA and 
general practice offered BCG received it, whilst 93.1% 
in the homeless group received it. In Ormerod study 
this outcome was not classified into groups. Nonethe-
less 29.9% that required BCG received it (240/1000).
Outcome of  chemoprophylaxis treatment was not as-
sessed. But in Bothamley et al, the proportion that 
started it was highest in the passive screening group. 
Whilst in Ormerod study chemoprohylaxis was offered 
to 12.4%. Outcomes presented in table 2 above.
Latent and Active Cases of  TB: Proportion of  latent 
TB cases was highest in the active screening groups of  
two of  the three studies that reported them (Monney et 
al and Verver et al). But proportions of  active TB cases 
were consistently higher in the passive group in three 
out of  the four studies (Monney et al, Ormerod and 
Verver et al) as shown in table 3.
Table 3 – Outcomes of  Screening; Latent and Active Cases of  TB Detected in the Various Studies
Treatment Outcomes for TB Cases: Percentage of  
cured was consistently higher in the active PoA screen-
ing. But percentage of  treatment completion was higher 
Table 4 – Outcome of  treatment for latent and active TB cases
Further Investigations: The outcomes of  further inves-
tigations that resulted in the diagnosis of  active cases of  
TB were consistently higher in the active PoA screening 
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attendees 
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Odds ratio = 0.5 95% CI 
(0.3 – 0.8) 
in the passive screening groups. The other treatment 
outcomes; failures, deaths, defaulters and transferred 
were not reported or inconsistent as presented in table 
4.
as shown in table 5. However Ormerod study did not 
report the outcome of  follow up investigations.
Table 5
Table 5: Further Investigations 
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55 (17.1% both active 
and passive groups) 
Number of 
TB cases 
3(2.8% 0% 0% 24(47.1%) 20(31.7%) Unknown unknown 
Symptom complaints and duration at diagnosis 
Monney et al 2005 Verver et al 2001 













2 months (at least 
8weeks) 
2.5 months (at least 
10weeks) 
4.2 (0 weeks) 10.5 (7.5 weeks) 
No significance test reported P-value < 0.001 
Table 5: Further Investigations 
Duration of  Symptoms Complaints, Period of  Infec-
tiousness and Hospitalisations: The percentages of  
people that did not complain of  symptoms at diagnosis 
in Monney et al were 49.3% (95% CI 37.4% - 61.2%) 
and 17.6% (95% CI 10.3% - 24.9%) in active and pas-
sive screening groups respectively. When analysis was 
limited to cases confirmed following further investiga-
tions and smear positives, they were; 42.2% (95% CI 
27.2% - 57.2%), 13% (95% CI 5.31% - 20.7%) and 
22.2% (95% CI 9.6% - 34.8%), 11.7% (95% CI 4.4% - 
19.0%) in active PoA and passive screening respectively. 
This information is summarised in table 5 above.
The duration of  symptoms complaints at diagnosis in 
the active PoA and PS in Verver et al were; 4.2 weeks 
and 10.5 weeks respectively (p-value< 0.001). The ac-
tive PoA screening reduced the total infectious period 
by 34% compared to 30% by PS. New entrants screened 
at PoA were 80% less likely to be hospitalised, OR = 0.2 
(95% CI 0.1 – 0.2).
Heterogeneity between Results of  Included Studies
A detail analysis of  the data proved that quantitative me-
ta-analysis was not appropriate. The reasons include;
-Inconsistent use of  TB screening tools resulting in 
methodological and clinical heterogeneities; use of  dif-
ferent screening questionnaire tools, targeting of  high 
risk groups
-Varying lengths of  study periods resulting in either im-
provement or deterioration of  TB programmes condi-
tions either in the host country or applicant's
-Use of  different effect sizes and missing data.
Methods for Economic Analysis
The search for cost studies for this systematic review 
was based on a predefined study selection form avail-
able on request with search strategies and study selec-
tion process.
Results for Economic Analysis: One economic evalua-
tion study was found. This was an embedded cost ef-
fectiveness analysis in one of  the included effectiveness 
studies (Bothamley et al, 2002).
Critique of  Economic Study: The objective of  the 
study was to assess the yield of  screening in 3 screen-
ing schemes; active PoA screening, screening in GP and 
screening of  a group of  homeless. The perspective was 
not clearly stated. However it can be assumed that a na-
tional healthcare payer perspective was adapted because 
the government is the provider of  all the alternatives 
and seems to have been conducted against the back-
ground that active PoA screening scheme has a poor 
yield and has been considered not effective 27.
The study examined both costs and effects. The effects 
examined were; the cost per person screened per case 
and the cost per person screened per case of  TB pre-
vented and the cost effectiveness was determined as 
savings or benefits gained in one scheme compared with 
the other alternatives. However a threshold for effec-
tiveness was not determined. Taking a National Health 
Service perspective, the analysis considered enough of  
the costs and consequences of  TB screening including 
further investigations (table of  the costs available on 
request). However capital/overhead and clerical costs 
were not available for GP. Indirect costs; transporta-
tion, TST reading, intangible and non-attendance were 
not included.
The costs were measured in pound-sterling and to aid 
comparison of  cost of  the different schemes at differ-
ent locations, authors chose an index of  cost/person 
screened per case of  TB prevented which allowed them 
to combine the outcomes of  interest; BCG vaccination, 
prevention, treatment and diagnosis of  TB. Incidence 
of  TB was left in its natural unit which was appropriate 
to do.
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No discounting despite the benefits of  TB prevention 
could go beyond one year. Although the study showed 
GP screening was most cost effective (table 6), sensitiv-
ity analysis to investigate the effect of  identifying a case 
of  TB showed that the benefit of  screening was highly 
sensitive to the number of  cases of  TB identified and 
case holding during treatment. However authors did 
not calculate any incremental cost effectiveness ratio.
Discussion
The objective of  this review was to assess the efficiency 
of  active PoA TB screening for new entrants compared 
with PS. Four poor quality retrospective cohort-studies 
met the review’s inclusion criteria. In terms of  some 
outcome measures of  interest; BCG and chemoproph-
ylaxis interventions and treatment outcomes were not 
consistently reported. However all studies reported 
these outcomes; number of  latent and active cases of  
TB.
PoA screening had the highest proportion of  invitees 
for TB screening and easily identified at risk groups due 
to their exposure status and offered them chemoproph-
ylaxis and BCG. However they had lower proportion of  
respondents and attendance to screening test. In terms 
of  detections of  latent and active TB cases, three out of  
the four studies showed that proportions of  both cases 
have been consistently higher in PS groups. However 
proportions of  latent and active TB cases detected by 
screening were higher in active PoA and PS groups of  
two studies; Verver et al and Bothamley et al respec-
tively.
Treatment outcomes were reported by two studies; 
these outcomes were available for 72% and 75% of  cas-
es that received treatment in active and passive screen-
ing groups respectively in Monney et al whilst treatment 
outcomes were available for 100% of  notifications in 
Verver et al. Active PoA detected TB earlier when it 
was drug-sensitive with higher cure rates, however high-
er proportions of  treatment completion and mortali-
ties were in passive screening groups. These could be 
due to the long period of  treatment during which im-
migrants change addresses frequently until they find a 
settled home and passive screening might had detected 
more severe cases not drug-sensitive.
Assessment of  outcomes of  further investigations was 
not assessed in primary studies. However it was shown 
to be higher in the PoA. Given that in some countries 
qualification for a residence/work permit is linked to 
full assessment of  immigrants TB status (Monney et al 
and Verver et al). This could be an encouragement for 
immigrants to comply with further investigations.
In terms of  signs and symptoms complaints, duration 
of  symptoms complaints was statistically significantly 
lower in active PoA screening groups. Subsequently this 
correlates with statistically significantly fewer numbers 
of  hospitalisations in the active PoA.
One economic evaluation study was found, a cost ef-
fectiveness analysis of  new entrants TB screening 
(Bothamley et al). The study showed that PS in general 
practice was most cost effective as the cost for screen-
ing immigrants in general practice, homeless and at 
PoA were; £1.26, £13.17 and £96.36 respectively and 
the cost per person screened per case of  TB prevented 
were; £6.32, £23.00 and £10.00 respectively.
Study limitations
All studies included in the review were retrospective co-
hort studies which have inherited fundamental limita-
tions such as recall and selection biases that put them 
at low level in the evidence hierarchy of  effectiveness 
studies. Thus the review highlights the need for robust 
study-design; cluster-randomised study/prospective co-
hort study in-order to assess the efficiency of  screening 
new entrants from TB endemic regions. Ideally a cost 
effectiveness study of  the alternatives conducted along-
side a cluster-randomised trial would be appropriate as 
this could influence the relationship between cost and 
effectiveness outcome ratios. 
Conclusion
This review showed some evidence that active PoA 
screening of  new entrants is worth doing. PoA screen-
ing more easily identified cases at high risk of  infection 
and offered them treatment/chemoprophylaxis. How-
ever PS detected significant proportion of  both active 
and latent cases.
Active PoA screening showed consistent clear benefit 
in reducing the period of  infectiousness which is an op-
portunity to protect others from TB transmission with 
subsequent avoidance of  hospital admissions with most 
relevance to TB control programmes in developed 
countries. However passive screening is marginally less 
costly both in screening an individual and preventing a 
case.
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